Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 94625 · Class III · LifeShare Blood Center
Key facts
| Event ID | 94625 |
|---|---|
| Recall numbers | B-0343-2024 |
| Recalling firm | LifeShare Blood Center |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but testing to verify white blood cell count exceeded time frame requirements for analysis, were distributed. |
| Initiation date | Feb 22, 2024 |
| Report date | May 29, 2024 |
| Termination date | May 21, 2024 |
| City | Shreveport |
| State | LA |
| Country | United States |
| FEI number | 2370879 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: